Summary An analysis has been made of the relationship between neuron specific enolase (NSE) 
The gamma-gamma dimer of the enzyme neuron specific enolase (NSE) has in small cell lung cancer (SCLC) been isolated in tissue cultures, tumour tissue and from patients serum Gazdar et al., 1981 Gazdar et al., , 1985 Marangos et al., 1982; Schmechel et al., 1978) . The serum level of NSE in patients with SCLC seems to be an important prognostic factor in SCLC (Akoun et al., 1985; J0rgensen et al., 1988) .
Routine classification of lung tumours is usually based on haematoxylin and eosin staining (HE). Newer With this semiquantitative gradation of the NSE-staining, a histological staining index (HSI) with the four groups was established: negative, 0-10%, 11-50% and >50% stained cells within sections.
Serum NSE was measured by a radioimmunoassay NSE-RIA (Pharmacia Diagnostics AB, Uppsala, Sweden) (Cooper et al., 1985) . The analyses were made at Diagnostic Development Unit, Old Medical School, Leeds.
All patients received chemotherapy according to ongoing protocols. Survival time was counted from the first day of treatment and differences were tested for statistical significance by the log rank method (Peto et al., 1977) . Differences of serum NSE levels between categories of HSI were tested by the Kruskal-Wallis one-way analysis (Kruskal, 1952) and the Mann-Whitney test (Mann & Whitney, 1947) . A significance level of P<0.05 was applied.
Results

Classification of immunoreactivity
Four out of the 60 tissue specimens did not contain malignant tissue and were excluded leaving 56 cases for assessment of NSE immunoreactivity. Characteristics of these patients are shown in Table I .
If staining was unevenly distributed, the classification was based on the most stained area. An example of this is shown in Figure 1 . Immunoreactivity was positive in 46 tumours (82%), distributed as 85% in LD and 77% in ED (Table II) . No significant difference was found between distribution of HSE indices in LD and ED (Table II) . Serum NSE and immunoreactions Serum NSE values were grouped according to HSE (Table  III) (Table VI) . A high frequency of NSE has been demonstrated in SCLC in tissues. In one study the frequency of NSE immunoreactivity was only one in five (Dhillon et al., 1982) . Later investigations proved NSE-positivity in 58% of 31 investigated tissues (Sheppard et al., 1984) , while 70% of 99 investigated biopsies from primary tumour as well as from metastases were NSE-immunoreactivity in a study by Bergh et al. (1985) . NSE was, however, found non-specific for SCLC, as NSE was positive in 66% of non-SCLC tumours vs 88% of SCLC tumours (Hirsch et al., 1988) and in 33 vs 56% respectively (Lee et al., 1988) . The concentrations of NSE in 11 tissue homogenates of SCLC were 35 times higher than in non malignant tissues and from four to nine times that measured in non-SCLC (Fujita et al., 1987) . Although obtained using very small specimens, our results are in agreement with those reported in previous studies. In our study, 82% of 56 primary tumours were NSE-positive. Our number of traumatised specimens corresponds with that reported by Bergh et al. (1985) from both primary tumours and metastases. As NSE is a soluble enzyme, the traumatised tissues might have achieved a higher gradation if not traumatised. Both studies thus stress the importance of well preserved tissues.
Serum-NSE and immunoreaction
Previous studies have been concerned with the presence of the NSE in tumour tissue (Dhillon et al., 1985; Sheppard et al., 1984; Carney et al., 1982; Fujita et al., 1987) and the serum levels of NSE in SCLC (Tapia et al., 1981; Cooper et al., 1985) . The presence of a relative high concentration of NSE in SCLC in both serum and tumour tissue are therefore well documented.
The correspondence between serum level and tissue content has not as far as we know been investigated. In our study similar distributions of HSI scores were achieved in LD and ED. The corresponding serum values were significantly higher in ED compared to LD. Finally there was no relationship between HSI score and serum levels of NSE. A HSI index based on light microscopic findings in the most stained area of the specimen is therefore not well correlated to serum levels which presumably reflects the overall NSE release from the tumour. Apparently, there exists no positive correlation between serum concentration and tumour content of NSE. Other techniques, such as flow cytometric analysis, may better overcome this bias related to heterogeneity of the tumour.
Prognosis
Univariate analysis of pretreatment prognostic factors including HSI left serum NSE and extent of disease as the most valuable factors. Multivariate analysis excluded HSI as a prognostic factor. An investigation by Dhillon et al. (1985) showed survival of four patients with NSE positive tumours compared to four patients with a negative NSE reaction. This is not in accordance with our results.
In conclusion, semiquantitative gradation of NSE in SCLC specimens enabled us to establish a scoring index. A high score was not associated with a high level of serum NSE. Both univariate and multivariate analysis chose serum NSE and PS as the most influential prognostic factors. Furthermore, as NSE is not specific for SCLC and heterogeneity of tumour tissue is common, serum NSE level is preferable for the estimation of prognosis.
